Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE: 300760)

Shenzhen Mindray Bio-Medical Electronics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	17,299	18,787	23,186	15,361	15,865	14,273
Cash & Short-Term Investments	17,660	18,787	23,186	15,361	15,865	14,273
Cash Growth	-10.20%	-18.97%	50.94%	-3.17%	11.15%	23.64%
Accounts Receivable	3,606	3,297	2,661	1,790	1,539	1,695
Other Receivables	187.62	195.1	149.11	126.04	279.03	244.74
Receivables	3,837	3,534	2,842	1,943	1,842	1,960
Inventory	4,857	3,979	4,025	3,565	3,617	2,265
Prepaid Expenses	-	60.57	92.31	58.1	123.87	26.41
Other Current Assets	749.2	515.29	461.19	407.58	183.29	200.48
Total Current Assets	27,103	26,875	30,606	21,335	21,632	18,724
Property, Plant & Equipment	9,588	8,221	6,290	5,131	4,129	3,659
Long-Term Investments	377.29	3,087	1,617	4,026	4,026	5
Goodwill	11,206	5,062	4,403	4,218	1,225	1,301
Other Intangible Assets	6,808	2,225	1,977	2,061	1,145	953.48
Long-Term Accounts Receivable	11.94	10.94	25.28	34.55	3.32	15.63
Long-Term Deferred Tax Assets	1,273	1,313	755.08	596.43	501.89	457.19
Long-Term Deferred Charges	467.31	417.23	379.45	224.24	204.16	167.13
Other Long-Term Assets	767.33	604	590.95	376.65	337.3	270.25
Total Assets	57,601	47,940	46,745	38,103	33,306	25,634
Accounts Payable	3,809	2,690	2,291	2,281	1,500	1,244
Accrued Expenses	3,038	3,139	3,136	2,428	2,063	1,386
Short-Term Debt	5.68	7.75	-	-	-	-
Current Portion of Long-Term Debt	115.6	0.43	-	-	-	-
Current Portion of Leases	-	104.3	97.22	85.08	-	-
Current Income Taxes Payable	683.72	471.65	287.22	256.75	136.31	98.26
Current Unearned Revenue	1,723	1,974	4,143	2,408	3,293	-
Other Current Liabilities	2,184	1,715	1,816	1,170	1,244	2,314
Total Current Liabilities	11,559	10,103	11,770	8,629	8,236	5,043
Long-Term Debt	0.38	1.38	-	-	-	-
Long-Term Leases	179.18	181.07	139.31	152.15	-	-
Long-Term Unearned Revenue	121.34	109.31	92.94	105.09	156.79	379.53
Long-Term Deferred Tax Liabilities	838.93	168.36	183.13	200.44	46.62	57.25
Other Long-Term Liabilities	2,889	4,031	2,561	2,048	1,576	1,537
Total Liabilities	15,588	14,594	14,746	11,135	10,016	7,017
Common Stock	1,212	1,212	1,212	1,216	1,216	1,216
Additional Paid-In Capital	6,938	7,091	7,509	8,153	8,153	8,171
Retained Earnings	29,184	25,288	24,369	18,994	14,032	9,207
Treasury Stock	-324.77	-663.28	-999.99	-999.99	-	-
Comprehensive Income & Other	84.19	157.27	-109.07	-409.74	-122.58	-1.31
Total Common Equity	37,094	33,085	31,981	26,953	23,278	18,593
Minority Interest	4,920	260.65	18.29	15.24	12.75	23.94
Shareholders' Equity	42,014	33,346	31,999	26,968	23,290	18,617
Total Liabilities & Equity	57,601	47,940	46,745	38,103	33,306	25,634
Total Debt	300.83	294.93	236.52	237.24	-	-
Net Cash (Debt)	17,359	18,492	22,949	15,124	15,865	14,273
Net Cash Growth	-10.55%	-19.42%	51.74%	-4.67%	11.15%	23.64%
Net Cash Per Share	14.32	15.26	18.96	12.45	13.05	11.74
Filing Date Shares Outstanding	1,213	1,214	1,209	1,213	1,216	1,216
Total Common Shares Outstanding	1,213	1,214	1,209	1,213	1,216	1,216
Working Capital	15,544	16,773	18,836	12,706	13,395	13,681
Book Value Per Share	30.59	27.25	26.44	22.23	19.15	15.29
Tangible Book Value	19,080	25,799	25,601	20,673	20,908	16,339
Tangible Book Value Per Share	15.73	21.25	21.17	17.05	17.20	13.44
Land	-	4,799	3,662	3,259	2,876	2,394
Machinery	-	3,283	2,822	2,366	1,924	1,715
Construction In Progress	-	2,461	1,803	1,126	929.84	975.17

Source: S&P Capital IQ. Standard template. Financial Sources.